NO982716L - FremgangsmÕte og blandinger for syntese av dioksalan-nukleotider med <beta>-konfigurasjon - Google Patents
FremgangsmÕte og blandinger for syntese av dioksalan-nukleotider med <beta>-konfigurasjonInfo
- Publication number
- NO982716L NO982716L NO982716A NO982716A NO982716L NO 982716 L NO982716 L NO 982716L NO 982716 A NO982716 A NO 982716A NO 982716 A NO982716 A NO 982716A NO 982716 L NO982716 L NO 982716L
- Authority
- NO
- Norway
- Prior art keywords
- dioxalane
- nucleotides
- beta
- synthesis
- compositions
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9525606.1A GB9525606D0 (en) | 1995-12-14 | 1995-12-14 | Method and compositions for the synthesis of dioxolane nucleosides with - configuration |
| PCT/CA1996/000845 WO1997021706A1 (en) | 1995-12-14 | 1996-12-13 | METHOD AND COMPOSITIONS FOR THE SYNTHESIS OF DIOXOLANE NUCLEOSIDES WITH β-CONFIGURATION |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO982716D0 NO982716D0 (no) | 1998-06-12 |
| NO982716L true NO982716L (no) | 1998-06-12 |
| NO309901B1 NO309901B1 (no) | 2001-04-17 |
Family
ID=10785435
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO982716A NO309901B1 (no) | 1995-12-14 | 1998-06-12 | FremgangsmÕte for syntese av dioksalan-nukleotider med <beta>- konfigurasjon |
Country Status (28)
| Country | Link |
|---|---|
| US (4) | US5922867A (no) |
| EP (1) | EP0970074B1 (no) |
| JP (1) | JP3229990B2 (no) |
| KR (1) | KR100406159B1 (no) |
| CN (1) | CN1080263C (no) |
| AP (1) | AP879A (no) |
| AT (1) | ATE214699T1 (no) |
| AU (1) | AU706328B2 (no) |
| BR (1) | BR9612351A (no) |
| CA (1) | CA2237730C (no) |
| DE (1) | DE69620042T2 (no) |
| DK (1) | DK0970074T3 (no) |
| EA (1) | EA000844B1 (no) |
| ES (1) | ES2172697T3 (no) |
| GB (1) | GB9525606D0 (no) |
| HK (1) | HK1017886A1 (no) |
| HU (1) | HU224076B1 (no) |
| IL (3) | IL144155A (no) |
| IN (1) | IN187349B (no) |
| MX (1) | MX9804701A (no) |
| NO (1) | NO309901B1 (no) |
| NZ (1) | NZ323855A (no) |
| OA (1) | OA11094A (no) |
| PL (1) | PL188447B1 (no) |
| PT (1) | PT970074E (no) |
| TW (1) | TW341574B (no) |
| WO (1) | WO1997021706A1 (no) |
| ZA (1) | ZA9610544B (no) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2001518899A (ja) | 1997-04-07 | 2001-10-16 | トライアングル ファーマシューティカルズ，インコーポレイティド | 他の抗ウイルス剤との組合せにおけるｍｋｃ−４４２の使用 |
| EP1535921A1 (en) | 1998-08-12 | 2005-06-01 | Gilead Sciences, Inc. | Method of manufacture of 1,3-oxathiolane nucleosides |
| US6979561B1 (en) * | 1998-10-09 | 2005-12-27 | Gilead Sciences, Inc. | Non-homogeneous systems for the resolution of enantiomeric mixtures |
| DK1140937T3 (da) * | 1998-12-23 | 2004-03-22 | Shire Biochem Inc | Antivirale nucleosid-analoger |
| AU2653200A (en) * | 1999-02-11 | 2000-08-29 | Biochem Pharma Inc. | Stereoselective synthesis of nucleoside analogues |
| DE60011637T2 (de) * | 1999-09-24 | 2004-11-11 | Shire Biochem Inc., Laval | Dioxolan nukleosidanalogen zur behandlung und vorbeugung von viralen infektionen |
| US6566365B1 (en) | 1999-11-04 | 2003-05-20 | Biochem Pharma Inc. | Method for the treatment of Flaviviridea viral infection using nucleoside analogues |
| EP1178051B1 (en) * | 2000-02-10 | 2008-05-28 | Mitsui Chemicals, Inc. | Process for selectively producing 1-phosphorylated sugar derivative anomer and process for producing nucleoside |
| AU3144801A (en) | 2000-02-11 | 2001-08-20 | Shire Biochem Inc. | Stereoselective synthesis of nucleoside analogues |
| WO2002051852A1 (fr) * | 2000-12-27 | 2002-07-04 | Mitsui Chemicals, Inc. | Procede de production d'un derive de saccharide non naturel |
| DK1389207T3 (da) * | 2001-03-01 | 2006-04-18 | Gilead Sciences Inc | Polymorfe og andre krystallinske former af cis-FTC |
| WO2003020222A2 (en) * | 2001-09-04 | 2003-03-13 | Merck & Co., Inc. | PYRROLO[2,3-d]PYRIMIDINES FOR INHIBITING RNA-DEPENDENT RNA VIRAL POLYMERASE |
| AU2002336864B2 (en) * | 2001-11-02 | 2006-08-17 | Shire Biochem Inc. | Pharmaceutical compositions for the treatment of leukemia comprising dioxolane nucleosides analogs |
| EP1569652A4 (en) | 2001-12-14 | 2008-07-02 | Pharmasset Inc | NUCLEOSIDES N SP 4 / SP-ACYLCYTOSINES FOR THE TREATMENT OF VIRAL INFECTIONS |
| US20050085638A1 (en) * | 2002-01-25 | 2005-04-21 | Shire Biochem Inc | Process for producing dioxolane nucleoside analogues |
| KR101108115B1 (ko) | 2002-08-06 | 2012-01-31 | 파마셋 인코포레이티드 | 1,3-디옥솔란 뉴클레오사이드의 제조 방법 |
| CN101724110B (zh) | 2002-10-15 | 2013-03-27 | 埃克森美孚化学专利公司 | 用于烯烃聚合的多催化剂体系和由其生产的聚合物 |
| DE10335061B4 (de) * | 2003-07-31 | 2005-11-17 | Wacker-Chemie Gmbh | Verfahren zur Herstellung von OH-geschützten [4-(2,6-damino-9H-purin-9-yl)-1,3-dioxolan-2-yl]methanol-Derivaten |
| KR101157468B1 (ko) * | 2004-02-03 | 2012-07-06 | 에모리 유니버시티 | 1,3-디옥솔란 뉴클레오시드 제조방법 |
| US7749531B2 (en) * | 2005-06-08 | 2010-07-06 | Indicator Systems International | Apparatus and method for detecting bacterial growth beneath a wound dressing |
| BRPI0813036A2 (pt) * | 2007-07-30 | 2017-10-24 | Rfs Pharma Llc | processo estereosseletivo para preparar derivados do nucleosídeo dioxolana de purina. |
| CN101862676B (zh) * | 2009-04-17 | 2012-01-25 | 中国石油化工股份有限公司 | 大孔径sba-15介孔材料-三氟甲磺酸铜复合催化剂、制备方法及应用 |
| CN103288806A (zh) * | 2013-07-02 | 2013-09-11 | 山东大学 | 一种曲沙他滨的合成方法 |
| WO2018022263A1 (en) | 2016-07-29 | 2018-02-01 | Exxonmobil Chemical Patents Inc. | Polymerization processes using high molecular weight polyhydric quenching agents |
| JP7337539B2 (ja) * | 2018-06-21 | 2023-09-04 | メディヴィル・アクチエボラーグ | 白血病療法のための塩基修飾シチジンヌクレオチド |
| WO2019245444A1 (en) | 2018-06-21 | 2019-12-26 | Medivir Ab | Base-modified cytidine nucleotides for leukemia therapy |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5276151A (en) * | 1990-02-01 | 1994-01-04 | Emory University | Method of synthesis of 1,3-dioxolane nucleosides |
| CN1086519A (zh) * | 1992-06-22 | 1994-05-11 | 伊莱利利公司 | 立体有择阴离子糖基化方法 |
-
1995
- 1995-12-14 GB GBGB9525606.1A patent/GB9525606D0/en active Pending
-
1996
- 1996-12-13 DK DK96941539T patent/DK0970074T3/da active
- 1996-12-13 AU AU10893/97A patent/AU706328B2/en not_active Expired
- 1996-12-13 EP EP96941539A patent/EP0970074B1/en not_active Expired - Lifetime
- 1996-12-13 ES ES96941539T patent/ES2172697T3/es not_active Expired - Lifetime
- 1996-12-13 IL IL14415596A patent/IL144155A/xx not_active IP Right Cessation
- 1996-12-13 CA CA002237730A patent/CA2237730C/en not_active Expired - Lifetime
- 1996-12-13 PT PT96941539T patent/PT970074E/pt unknown
- 1996-12-13 IN IN2810DE1996 patent/IN187349B/en unknown
- 1996-12-13 HU HU9901050A patent/HU224076B1/hu active IP Right Grant
- 1996-12-13 US US08/849,722 patent/US5922867A/en not_active Expired - Lifetime
- 1996-12-13 WO PCT/CA1996/000845 patent/WO1997021706A1/en active IP Right Grant
- 1996-12-13 KR KR10-1998-0704473A patent/KR100406159B1/ko not_active IP Right Cessation
- 1996-12-13 IL IL12466396A patent/IL124663A/en not_active IP Right Cessation
- 1996-12-13 AT AT96941539T patent/ATE214699T1/de not_active IP Right Cessation
- 1996-12-13 AP APAP/P/1998/001252A patent/AP879A/en active
- 1996-12-13 TW TW085115392A patent/TW341574B/zh active
- 1996-12-13 BR BR9612351A patent/BR9612351A/pt not_active Application Discontinuation
- 1996-12-13 NZ NZ323855A patent/NZ323855A/xx unknown
- 1996-12-13 EA EA199800555A patent/EA000844B1/ru not_active IP Right Cessation
- 1996-12-13 CN CN96199879A patent/CN1080263C/zh not_active Expired - Lifetime
- 1996-12-13 DE DE69620042T patent/DE69620042T2/de not_active Expired - Lifetime
- 1996-12-13 ZA ZA9610544A patent/ZA9610544B/xx unknown
- 1996-12-13 JP JP52157397A patent/JP3229990B2/ja not_active Expired - Lifetime
- 1996-12-13 PL PL96327443A patent/PL188447B1/pl not_active IP Right Cessation
-
1998
- 1998-06-09 OA OA9800077A patent/OA11094A/en unknown
- 1998-06-11 MX MX9804701A patent/MX9804701A/es unknown
- 1998-06-12 NO NO982716A patent/NO309901B1/no unknown
-
1999
- 1999-02-17 US US09/251,431 patent/US6069250A/en not_active Expired - Lifetime
- 1999-05-17 HK HK99102184A patent/HK1017886A1/xx not_active IP Right Cessation
-
2001
- 2001-07-05 IL IL14415501A patent/IL144155A0/xx unknown
- 2001-11-16 US US09/987,845 patent/US20020058670A1/en not_active Abandoned
-
2002
- 2002-10-02 US US10/262,107 patent/US20030060476A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO982716D0 (no) | FremgangsmÕte og blandinger for syntese av dioksalan-nukleotider med <beta>-konfigurasjon | |
| LV12018A (lv) | 2-metil-tieno-benzodiazepina pagatavosanas process un ta kristaliskas formas | |
| NO20016226L (no) | Fremgangsmåte for fremstilling av substituerte formamider | |
| NO20000227L (no) | Krystallmodifikasjon av et N-fenyl-2-pyrimidinaminderivat, fremgangsmåte for dens fremstilling og dens anvendelse | |
| NO983004L (no) | Laktonderivater av 17<beta>-karboksy-karbotio- og amidandrostanderivater | |
| NO971895L (no) | Inhibitorer av apolipoprotein <beta>-syntesen | |
| FI931408A0 (fi) | Anordning foer fraesning av amorfiska staolremsor | |
| NO20005187D0 (no) | n-sats syntese av 2-oksazolidinonderivater | |
| NO982237L (no) | FremgangsmÕte for fremstilling av fenylimidazolidinderivater | |
| NO950814D0 (no) | Fremgangsmåte for fremstilling og rensing av joderte kontrastmidler | |
| AU3866089A (en) | Derivatives of nucleosides which may be used for the synthesis of marked oligonucleotides and oligonucleotides obtained from these derivatives and their synthesis | |
| BR9508380A (pt) | Derivados de azalonas heterocíclicos anti-helicobacter | |
| NO986086L (no) | FremgangsmÕte for fremstilling av 17-estere av 9<alfa>,21-dihalo-pregnan-11<beta>,17<alfa>-diol-20-oner | |
| NO943652D0 (no) | Fremgangsmåte for fremstilling av 3-aminopyridiner fra 3-nitropyridiner | |
| NO963187D0 (no) | Fremgangsmåte for syntese av gamma-pyroner | |
| NO940171L (no) | Fremgangsmåte for kontinuerlig fremstilling av dimetoksyetanal | |
| NO305363B1 (no) | FremgangsmÕte for fremstilling av substituerte indolonderivater og forbindelsene derav | |
| NO308471B1 (no) | FremgangsmÕter for fremstilling av lorakarbefmonohydrat og krystallinsk anhydratform av lorakarbef | |
| NO971419L (no) | Fremgangsmåte for fremstilling av 1,3-alkendioler og 3-hydroksyaldehyder | |
| NO972129D0 (no) | Fremgangsmåte for fremstilling av 1-halo-3-trialkylsilanyl-benzenderivater | |
| GB9011623D0 (en) | Synthesis of nucleotide and nucleoside derivatives | |
| NO308358B1 (no) | FremgangsmÕte ved fremstilling av cykloheptimidazolderivater og synteseintermediat dertil | |
| NO962809D0 (no) | Fremgangsmåte for fremstilling av N-substituerte 4-ketoprolinderivater | |
| NO990185D0 (no) | FremgangsmÕte for fremstilling av naftypyridoner og mellomprodukter | |
| NO964519D0 (no) | Fremgangsmåte for fremstilling av chitosanalkylderivater |